INM 8-K: Acquisition
InMed Pharmaceuticals completed its previously
Filed with the SEC on · accession 0001193125-26-462017
INM filed a 8-K (current report) with the SEC on Nov 16, 2026. InMed Pharmaceuticals completed its previously announced business combination with Mentari Therapeutics on November 6, 2026, and the combined company now operates as Mentari Therapeutics, Inc. This 8-K furnishes Mentari's unaudited condensed consolidated financial statements and MD&A for the three…
Summary of the filing
InMed Pharmaceuticals completed its previously announced business combination with Mentari Therapeutics on November 6, 2026, and the combined company now operates as Mentari Therapeutics, Inc. This 8-K furnishes Mentari's unaudited condensed consolidated financial statements and MD&A for the three and nine months ended September 30, 2026.
Key details
✦ Ask GOAX AI about this filing — what it means for INM, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for INM?
Click hereFrequently asked questions
What did INM file with the SEC on Nov 16, 2026?
INM filed a 8-K (Acquisition). InMed Pharmaceuticals completed its previously announced business combination with Mentari Therapeutics on November 6, 2026, and the combined company now operates as Mentari Therapeutics, Inc. This 8-K furnishes Mentari's unaudited condensed consolidated financial statements and MD&A for the three and nine months ended September 30, 2026.
What does a acquisition mean for INM stock?
A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other INM SEC filings
- SCHEDULE 13G · SEC filingNov 13, 2026
- SCHEDULE 13G · SEC filingNov 13, 2026
- SCHEDULE 13D · Activist campaignNov 12, 2026
- 8-K · AcquisitionNov 10, 2026
- 8-K · AcquisitionNov 9, 2026
- 8-K · Stock splitNov 5, 2026
- 8-K · Stock splitNov 5, 2026
- 10-Q · SEC filingNov 3, 2026
- 8-K · SEC filingNov 3, 2026
- 424B3 · Material agreementOct 28, 2026
Get alerts when INM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days